ArticleMedical physics2025
Scenario-free robust optimization algorithm for IMRT and IMPT treatment planning.
Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scenario-free robust optimization algorithm for IMRT and IMPT treatment planning.Medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundRobust treatment planning algorithms for intensity modulated proton therapy (IMPT) and intensity modulated radiation therapy (IMRT) allow for uncertainty reduction in the delivered dose distributions through explicit inclusion of error scenarios. Due to the curse of dimensionality, application of such algorithms can easily become computationally prohibitive. PURPOSE: This work proposes a scenario-free probabilistic robust optimization algorithm that overcomes both the runtime and memory limitations typical of traditional robustness algorithms.
methodsThe scenario-free approach minimizes cost-functions evaluated on expected-dose distributions and total variance. Calculation of these quantities relies on precomputed expected-dose-influence and total-variance-influence matrices, such that no scenarios need to be stored for optimization. The algorithm is developed within matRad and tested in several optimization configurations for photon and proton irradiation plans. A traditional robust optimization algorithm and a margin-based approach are used as a reference to benchmark the performance of the scenario-free algorithm in terms of plan quality, robustness, and computational workload.
resultsThe implemented scenario-free approach achieves plan quality similar to traditional robust optimization algorithms, and it reduces the distribution of standard deviation within selected structures when variance reduction objectives are defined. Avoiding the storage of individual scenario information allows for the solution of treatment plan optimization problems, including an arbitrary number of error scenarios. The observed computational time required for optimization is close to a nominal, non-robust algorithm and substantially lower compared to the traditional robust approach. Estimated gains in relative runtime range from approximately
conclusionThis work introduces a novel scenario-free optimization approach relying on the precomputation of probabilistic quantities while preserving compatibility with state-of-the-art uncertainty modeling. The measured runtime and memory footprint are independent of the number of included error scenarios and similar to those of non-robust margin-based optimization algorithms, while achieving the required dose and robustness specifications under multiple different optimization conditions. These properties make the scenario-free approach suitable and beneficial for 3D and 4D robust optimization involving a high number of error scenarios and/or CT phases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.